NCT04145349 2025-12-08CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell TumorEli Lilly and CompanyPhase 1/2 Active not recruiting30 enrolled 16 charts